BMRN vs LOPE · P/E 40, rev $1.76B vs P/E 23, rev $572.8M
Biomarin Pharmaceutical Inc (BMRN) versus Grand Canyon Education Inc (LOPE) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Grand Canyon Education Inc (LOPE) is a education & training services company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported LOPE revenue for 2026-06-30 was $572.8M. Net income was $121.2M. Revenue was up 85.5% from 2026-03-31 to 2026-06-30. LOPE currently screens at market cap $5.20B and trailing P/E 23.0.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. LOPE currently screens at market cap $5.20B and trailing P/E 23.0.
Not investment advice. Open the BMRN and LOPE stock pages for the full models.
Not investment advice.